缩写名/全名 |
J OVARIAN RES
Journal of Ovarian Research |
||||||||||||||||||||
ISSN号 | 1757-2215 | ||||||||||||||||||||
研究方向 | REPRODUCTIVE BIOLOGY- | ||||||||||||||||||||
影响因子 | 2015:2.502, 2016:2.461, 2017:2.367, 2018:2.469, 2019:2.989, | ||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||
出版周期 | |||||||||||||||||||||
年文章数 | 122 | ||||||||||||||||||||
出版年份 | 2008 | ||||||||||||||||||||
是否OA | Yes | ||||||||||||||||||||
审稿周期(仅供参考) | >12周,或约稿 |
||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||
投稿链接 | https://www.editorialmanager.com/jovr/default.aspx | ||||||||||||||||||||
投稿官网 | http://ovarianresearch.biomedcentral.com/ | ||||||||||||||||||||
h-index | 36 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1757-2215%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Effects of hysterectomy with simultaneous bilateral salpingectomy on the subsequent pelvic mass Author: Xiaopei Chao, Xiaoxia Wang, Yu Xiao, Mingliang Ji, Shu Wang, Honghui Shi, Qingbo Fan, Lan Zhu, Jinhua Leng, Dawei Sun, Jinghe Lang Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-019-0504-6 DOI |
2. | Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses Author: Zhengmao Zhang, Kaiyun Qin, Wenzhe Zhang, Botao Yang, Chen Zhao, Xiaojing Zhang, Fenghua Zhang, Lianmei Zhao, Baoen Shan Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-019-0499-z DOI |
3. | Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients Author: Lei Zhang, Min Luo, Hongying Yang, Shaoyan Zhu, Xianliang Cheng, Chen Qing Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-019-0494-4 DOI |
4. | Correction to: Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system Author: Kaijian Ling, Lupin Jiang, Shi Liang, Joseph Kwong, Leiyan Yang, Yudi Li, PingYin, Qingchun Deng, Zhiqing Liang Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-019-0487-3 DOI |
5. | Comparison and analysis of the clinicopathological features of SCEO and ECOM Author: Ting Wang, Xiaodan Zhang, Zhiying Lu, Junyan Wang, Keqin Hua Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-019-0485-5 DOI |
6. | Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis Author: Xinshuai Wang, Dejiu Kong, Chaokun Wang, Xuezhen Ding, Li Zhang, Mengqi Zhao, Jing Chen, Xiangyun Xu, Xiaochen Hu, Junqiang Yang, Shegan Gao Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-019-0482-8 DOI |
7. | Overexpression of CCDC69 activates p14<Superscript>ARF</Superscript>/MDM2/p53 pathway and confers cisplatin sensitivity Author: Long Cui, Fang Zhou, Cui Chen, Chi Chiu Wang Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-019-0479-3 DOI |
8. | Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer Author: Ying Ying Su, Li Sun, Zhi Rui Guo, Jin Chang Li, Ting Ting Bai, Xiao Xiao Cai, Wen Han Li, Ye Fei Zhu Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-018-0477-x DOI |
9. | Recurrent ovarian mixed germ cell tumor with unusual malignant transformation: a case report Author: Yi-Le Lee, Chiung-Ru Lai, Ming-Shyen Yen Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-018-0476-y DOI |
10. | Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets Author: Kaipeng Xie, Chenyang Fu, Suli Wang, Hanzi Xu, Siyu Liu, Yang Shao, Zhen Gong, Xiaoli Wu, Bo Xu, Jing Han, Juan Xu, Pengfei Xu, Xuemei Jia, Jiangping Wu Journal: Journal of Ovarian Research, 2019, Vol.12, , DOI:10.1186/s13048-018-0475-z DOI |
|
|